Brain health is emerging as a crucial driver of social and economic sustainability in Europe. Neurological conditions like epilepsy not only impact quality of life, inclusion, and productivity but also place increasing pressure on healthcare systems and economies. In particular, despite affecting 6 million people in Europe, epilepsy remains under-recognized in both national and European policy agendas.

This event, hosted in the European Parliament by MEP Romana Jerković, offers a key opportunity for dialogue and reflection. Drawing on data and insights from the 2025 edition of the Headway Report, the discussion will focus on epilepsy as a high-impact area for improving public health and economic outcomes, and will call for the integration of brain health into the broader European policy framework.

Through the involvement of policymakers, researchers, patient associations, and scientific societies, the event will explore how to shift from fragmented responses to a coordinated “Brain Health for All” approach. Special attention will be given to the implementation of the Intersectoral Global Action Plan on Epilepsy and Other Neurological Disorders (IGAP), the potential of the brain economy, and the role of EU institutions in driving forward a shared call to action, underlining how promoting brain health means unlocking human potential, reducing inequalities, and strengthening the foundations for a healthier, more inclusive Europe.

An initiative on Brain Health launched in partnership with Angelini Pharma.